| Category | Summary |
|---|---|
| Identity/domains | • Verified target: human **PIWIL1/HIWI**, UniProt **Q96J94**, a **PIWI-subfamily Argonaute** protein, matching the user-supplied identifier and literature usage for HIWI/PIWIL1. • Domain architecture reported as **PAZ, MID, PIWI**; PIWIL1 is described as an ~**852 aa** protein with RNase H-like PIWI domain catalytic potential. • Core biochemical role is **small-RNA-guided endonuclease (“slicer”)** activity rather than classical metabolism; the PIWI domain cleaves complementary RNA targets guided by bound piRNAs. (pqac-00000003, pqac-00000005, pqac-00000007) |
| Molecular function | • Binds **piRNAs** (typically ~24–32/31 nt, 3′ 2′-O-methylated) to form PIWI–piRNA ribonucleoprotein complexes/piRISC. • Main established function is **germline genome defense**, especially **transposon silencing** and maintenance of spermatogenesis/fertility. • Can mediate **post-transcriptional silencing** by slicing target RNAs and, in broader PIWI/piRNA models, contribute to **epigenetic regulation** by recruiting chromatin/DNA methylation machinery. (pqac-00000003, pqac-00000004, pqac-00000005, pqac-00000010) |
| Pathway modules | • **Primary biogenesis/loading:** long piRNA-cluster precursors are cleaved by **PLD6/ZUC/MitoPLD** on mitochondria, loaded into PIWI proteins, then trimmed (e.g., **PNLDC1/Trimmer**) and methylated by **HENMT1/Hen1**. • **Effector/slicer module:** mature PIWIL1–piRNA complexes cleave complementary RNAs in the cytoplasm. • **Secondary amplification/ping-pong:** mechanistically central to piRNA biology, but evidence indicates **PIWIL1/MIWI is mainly primary-piRNA-loaded** in mammalian pachytene cells, with ping-pong more strongly attributed to PIWIL2/MILI. • **Nuclear silencing module:** PIWI/piRNA complexes can also support transcriptional silencing via chromatin modifiers in general pathway models. (pqac-00000009, pqac-00000010, pqac-00000011, pqac-00000012, pqac-00000013, pqac-00000015, pqac-00000016) |
| Localization | • In human testis, PIWIL1 protein is detected in the **cytoplasm of late pachytene spermatocytes and spermatids**, disappearing in elongated spermatids. • Signal concentrates in structures consistent with **mitochondrial cement/nuage** in pachytene cells and the **chromatoid body** in spermatids. • In CRC cell models, PIWIL1 is **nuclear during interphase** and relocalizes to **centrosomes/MTOC during mitosis**, co-localizing with **γ-tubulin**; tumor tissues show mainly **cytoplasmic** staining. (pqac-00000033, pqac-00000030, pqac-00000025, pqac-00000026, pqac-00000035) |
| Key interactors | • Direct molecular partner class: **piRNAs**. • Biogenesis/processing factors linked in pathway models include **PLD6/ZUC**, **MOV10L1**, **PNLDC1**, **HENMT1**, and the helicase **DDX4/Vasa**. • PIWI family proteins interact with **Tudor-domain proteins (TDRDs)** in arginine-methylation-dependent assemblies; human/oocyte literature also places PIWI proteins in complexes with mitochondrial/piRNA biogenesis machinery. • In CRC mitosis work, PIWIL1 associates spatially with **γ-tubulin/centrosomal machinery**. (pqac-00000007, pqac-00000010, pqac-00000011, pqac-00000015, pqac-00000025) |
| Human germline evidence | • Human testis study of **222 biopsies** found PIWIL1 and HENMT1 coexpressed in pachytene spermatocytes/spermatids; PIWIL1 expression tracked germ-cell content and was nearly absent from Sertoli-cell-only tissue. • PIWIL1 was expressed in all normal spermatogenesis samples, all hypospermatogenesis samples, **96%** of arrest samples, but only **5%** of Sertoli-cell-only samples. • Low/absent piRNA-pathway components were associated with higher **LINE-1** expression, supporting a role in transposon repression in human testis. • A 2024 human genetics study identified **39 infertile men** carrying biallelic variants in **14 piRNA-pathway genes including PIWIL1**, with reduced pachytene piRNAs and LINE1 de-silencing, establishing piRNA-pathway disruption as a major cause of spermatogenic failure. (pqac-00000029, pqac-00000028, pqac-00000027) |
| Somatic/cancer evidence | • Reviews from 2023–2024 consistently note that PIWIL1 is normally germline-restricted but is aberrantly expressed in multiple tumors, motivating biomarker interest. • In HCC, PIWIL1 mRNA was reported as elevated in tumor tissue and serum versus controls. • In CRC models, PIWIL1 is overexpressed and appears linked to a **piRNA-independent** role in mitotic fidelity/cell-cycle progression, especially centrosome-associated behavior during mitosis. • Somatic PIWI/piRNA literature remains mechanistically heterogeneous, with stronger evidence for association than for universal canonical piRNA function in all tumors. (pqac-00000003, pqac-00000007, pqac-00000017, pqac-00000022, pqac-00000024) |
| Quantitative findings 2017-2024 | • Human testis cohort: **222 biopsies** analyzed; PIWIL1 detected in **all** normal spermatogenesis and hypospermatogenesis samples, **96%** of arrest samples, **~70%** of tumors, **5%** of Sertoli-cell-only samples. • Correlation with LINE-1 in germ-cell-containing samples was strong (**Spearman r = 0.94** for PIWIL1 vs L1 in Nsp/Hyp groups). • HCC study: **50 HCC patients** and **25 controls**; serum PIWIL1 ROC **AUC 1.0**, sensitivity **100%**, specificity **100%**, p<0.001; tissue PIWIL1 ROC **AUC 0.80**, sensitivity **80%**, specificity **72%**, p<0.001; serum PIWIL1 OR **3.87** (95% CI **1.23–8.36**), p<0.001. • CRC preprint: TCGA/GTEx comparison showed PIWIL1 upregulation in CRC with **N=650**, **p≤0.0001**; PIWIL1 knockdown reduced mRNA/protein by **~70%** at 72 h and increased G2/M arrest/mitotic defects. (pqac-00000028, pqac-00000017, pqac-00000018, pqac-00000020, pqac-00000024, pqac-00000025, pqac-00000035) |
| Notes/caveats | • The **gene identity is not ambiguous here**: the literature aligns with human **PIWIL1/HIWI** and the supplied UniProt record. • However, much mechanistic detail comes from **cross-species PIWI/piRNA biology** and is often inferred to human PIWIL1. • Some cancer studies may detect **non-canonical piRNA-like fragments** rather than bona fide piRNAs; several reviews explicitly caution about annotation and antibody-validation issues. • The CRC centrosome study is a **2024 preprint**, so its mitotic localization/function findings should be treated as provisional until peer-reviewed. (pqac-00000001, pqac-00000003, pqac-00000009, pqac-00000022) |


*Table: This table summarizes the strongest evidence for human PIWIL1/HIWI identity, mechanism, localization, interacting pathway components, and quantitative findings from 2017–2024. It is designed as a compact functional-annotation reference with direct context-ID citations for each row.*